At Queen Mary University of London, researchers have found that a cellular enzyme called AMPK — long suspected to be entangled with the biology of aging — can extend lifespan in fruit flies, worms, and yeast when deliberately activated. The discovery marks a rare step from correlation to causation in longevity science, offering a cleaner view of how organisms might be coaxed to live longer by tuning their response to energy scarcity. Yet the path from simple organisms to human beings remains uncharted, and the researchers themselves urge patience over prescription.
Scientists identify AMPK enzyme as potential key to extending human lifespan
The switch must be set correctly, not jammed on.
Mark
So they found that activating this enzyme extended life in flies and worms. Does that mean we should expect it to work in humans?
Mimi
Not yet. The mouse experiments are the real test, and those didn't show lifespan extension—only signs that the pathway was active. That's a meaningful difference.
Luke
Right. And we should note: three weeks in mice is a very short window. You can't measure lifespan extension in three weeks. They're being honest about needing longer studies.
Mark
What about the dosage problem? They said too much of the compound shortened life.
Mimi
That's the critical finding, actually. It means AMPK activation isn't a simple "more is better" situation. There's a sweet spot, and overshooting it appears to be harmful.
Luke
Which also means any future drug would need precise calibration. You can't just give people a pill and hope. The biology doesn't work that way.
Mark
So why is this research important if we're still so far from human applications?
Mimi
Because it's the first time they've directly tested whether activating AMPK itself—not just observing it in nature—can influence lifespan. They used a clean compound and showed causation, not just correlation.
Luke
And they did it across three very different organisms. That's real evidence the pathway matters. But the mouse data is a reminder that simple organisms don't always predict what happens in mammals.
Mark
What happens next?
Mimi
Longer mouse studies. If AMPK activation can extend lifespan in mice, then you have a real candidate for human research. If it doesn't, the pathway may still matter, but the mechanism might be different in mammals.
Luke
And they need to solve the dosage problem. A drug that works only in a narrow window is harder to develop and use safely.
Der Puls
- A compound called 991 has demonstrated the ability to extend lifespan across three evolutionarily distant organisms, lending unusual credibility to AMPK as a genuine longevity mechanism rather than a coincidental marker.
- The causal link was confirmed when the lifespan extension disappeared entirely in worms and yeast engineered to lack functional AMPK — ruling out the compound itself as the source of the effect.
- A critical warning shadows the findings: higher doses of 991 shortened lifespans in some experiments, revealing that the difference between benefit and harm may come down to precise calibration.
- Mouse trials showed biological signs of AMPK activation in tissues after three weeks, but no lifespan extension — leaving the mammalian question, and by extension the human one, unresolved.
- Lead researchers are actively discouraging supplement-seeking behavior, emphasizing that the science is still navigating the vast biological distance between a fruit fly and a human being.
At Queen Mary University of London, researchers have found that a cellular enzyme called AMPK — long suspected to be entangled with the biology of aging — can extend lifespan in fruit flies, worms, and yeast when deliberately activated. The discovery marks a rare step from correlation to causation in longevity science, offering a cleaner view of how organisms might be coaxed to live longer by tuning their response to energy scarcity. Yet the path from simple organisms to human beings remains uncharted, and the researchers themselves urge patience over prescription.
Scientists at Queen Mary University of London have identified AMPK, a cellular enzyme that functions like a fuel gauge inside living cells, as a potential key to extending lifespan. When energy runs low, AMPK triggers a coordinated response — ramping up energy production, recycling cellular components, and slowing growth. Researchers had long suspected this pathway was connected to aging, but lacked a precise enough tool to test the idea directly.
Using a compound called 991 to activate AMPK, the team demonstrated lifespan extension in fruit flies, nematode worms, and fission yeast — three organisms separated by enormous evolutionary distance. Crucially, when the experiment was repeated in worms and yeast engineered to lack functional AMPK, the effect vanished entirely, pointing to a direct causal relationship rather than a side effect of the compound.
The findings come with a significant caveat: more is not better. Higher doses of 991 actually shortened lifespan in some tests, suggesting that the benefit depends on hitting a precise activation level. Co-author Charalampos Rallis was explicit in cautioning against anyone drawing premature conclusions or reaching for supplements.
The research team, spanning six European and British institutions, also tested the compound in mice. After three weeks, they detected signs of AMPK activation in the animals' tissues — consistent with longevity-related processes — but no extension of lifespan. Whether longer treatment timescales might change that outcome remains an open question. The gap between a nematode worm and a mammal is not trivial, and the harder work of understanding whether this cellular switch can be safely and effectively used in creatures as complex as humans is only beginning.
Researchers at Queen Mary University of London have identified a cellular enzyme that appears to govern how organisms respond to energy scarcity—and in doing so, may have found a lever for extending lifespan. The enzyme, called AMPK, acts as a fuel gauge inside cells. When energy runs low, it triggers a cascade of adaptations: cells ramp up energy production, recycle their own components, and dial back growth. Scientists have long suspected this pathway connects to aging, but testing the theory directly has proven difficult. Now, using a compound called 991 that activates AMPK, researchers have demonstrated that switching on this enzyme extended the lifespan of fruit flies, nematode worms, and fission yeast—three organisms separated by vast evolutionary distance.
The findings, published in the journal Aging Cell, represent a rare moment of clarity in longevity research. The team did not merely observe that AMPK activation correlated with longer life; they tested causation. When researchers repeated the experiment using worms and yeast that lacked functional AMPK, the lifespan extension vanished. This specificity matters. It suggests the effect flows directly from AMPK activation, not from some secondary consequence of the compound.
But the story carries a crucial caveat. More is not better. Higher doses of the compound 991 actually shortened lifespan in some experiments, a finding that underscores how delicate the balance is. Getting AMPK activation to the right level is essential; overshooting the mark appears to be harmful. Charalampos Rallis, a reader in genetics and genomics at Queen Mary University and a co-author of the study, put it plainly: the switch must be set correctly, not jammed on. He cautioned against anyone rushing to buy supplements based on this work.
The research team, drawn from six institutions across Europe and the United Kingdom, also tested the compound in mice. After three weeks of treatment, they observed signs that AMPK had been activated in the animals' tissues. Yet the mice did not live longer. The researchers noted that the changes they detected were consistent with longevity-related processes, suggesting the pathway may be working as expected—but that longer timescales may be needed to see whether AMPK activation can actually extend mammalian lifespan and improve what researchers call healthspan, the period of life spent in good health.
The gap between fruit flies and mice is not trivial. Mice are mammals, closer to humans in their biology and complexity. The fact that AMPK activation shows promise in simpler organisms but has not yet demonstrated lifespan extension in mammals leaves the human question open. Rallis's own words capture the moment: for years, scientists knew this switch was connected to aging but lacked a tool clean enough to test the idea. Now they have that tool. What remains is the harder work of understanding whether it can be wielded safely in creatures as intricate as we are.
Bemerkenswerte Zitate
We have known for years that this switch is connected to aging. What we did not have was a drug clean enough to test the idea properly.— Charalampos Rallis, Queen Mary University of London
I would not want anyone to reach for a supplement on the back of this. Too much of the drug shortened life in our experiments.— Charalampos Rallis, Queen Mary University of London
Möchten Sie die ganze Geschichte?
Das Original lesen bei ttownmedia.com ↗